David Gryska

Mr. David W.
Gryska is an Independent Director at Definium Therapeutics, Inc. and an Independent Director at Forte Biosciences, Inc. He is on the Board of Directors at Definium Therapeutics, Inc. and Forte Biosciences, Inc. Mr. Gryska was previously employed as an Independent Director by Aerie Pharmaceuticals, Inc., a Chief Financial Officer & Executive Vice President by Incyte Corp., an Independent Director by PDL BioPharma, Inc., a President, CEO, COO & Director by Myrexis, Inc., an Independent Director by Argos Therapeutics, Inc., a Lead Independent Director by Hyperion Therapeutics, Inc., a Chief Financial Officer & Senior Vice President by Celgene Corp., an Independent Director by Seagen, Inc., a Principal by Strategic Consulting Group, Inc., a Chief Financial Officer & Senior Vice President by Scios, Inc., a Chief Financial Officer & Vice President-Finance by Cardiac Pathways Corp., and an Audit Partner by Ernst & Young LLP.
He also served on the board at GW Pharmaceuticals Ltd., Aerie Pharmaceuticals, Inc., CoTherix, Inc., Medpace, Inc. and Phenomix Corp.
He received his undergraduate degree from Loyola University of Chicago and an MBA from Golden Gate University.